Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK)
HKD 0.28
(3.7%)
HKD 0.28
(3.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 53.68 Million | 61.22 Million | -69.92 Million | 93.64 Million | 60.35 Million | 25.03 Million |
| Net Income | 30.67 Million | 82.26 Million | 39.11 Million | 50.21 Million | 78.82 Million | 67.64 Million |
| Depreciation & Amortization | 33.64 Million | 35.94 Million | 30.26 Million | 25.7 Million | 23.65 Million | 19.63 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -19.03 Million | -51.39 Million | -135.02 Million | 20.35 Million | -29.46 Million | -43.96 Million |
| Other non-cash items | 8.4 Million | -5.58 Million | -4.27 Million | -2.62 Million | -12.66 Million | -18.28 Million |
| Investing Cash Flow | 60.89 Million | 10.75 Million | -181.56 Million | -30.68 Million | -25.05 Million | -18.39 Million |
| Investments in PPE | -15.36 Million | -19.71 Million | -15.07 Million | -37.95 Million | -33.46 Million | -27.67 Million |
| Acquisitions | - | - | -63.68 Million | 6.63 Million | -387.17 Million | -312.83 Million |
| Investment purchases | - | - | -245 Million | -274 Million | -395 Million | -322 Million |
| Sales/Maturities of investments | 70 Million | 24 Million | 135 Million | 270 Million | 395 Million | 322 Million |
| Other Investing Activities | 6.26 Million | 6.47 Million | 7.19 Million | 4.63 Million | 395.58 Million | 322.11 Million |
| Financing Cash Flow | -32.47 Million | -9.02 Million | 66.74 Million | -35.28 Million | 25.33 Million | -33.78 Million |
| Debt repayment | -139.89 Million | -107.18 Million | -19 Million | -60 Million | -1.65 Million | -60 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -20.24 Million | 98.16 Million | 85.74 Million | 24.71 Million | 26.99 Million | 26.21 Million |
| Accounts receivables | 5.88 Million | -73.29 Million | 30.46 Million | 23.76 Million | -54.51 Million | -39.93 Million |
| Accounts payables | -5.88 Million | 73.29 Million | -30.46 Million | -23.76 Million | 54.51 Million | - |
| Inventory | -10.66 Million | -45.52 Million | 3.84 Million | 1.96 Million | -23.21 Million | 27.96 Million |
| Other working capital | -8.36 Million | -5.86 Million | -138.86 Million | 18.38 Million | -6.25 Million | -71.92 Million |
| Cash at beginning of period | 290.09 Million | 227.14 Million | 411.88 Million | 384.21 Million | 323.57 Million | 350.72 Million |
| Cash at end of period | 372.2 Million | 290.09 Million | 227.14 Million | 411.88 Million | 384.21 Million | 323.57 Million |
| Capital Expenditure | -15.36 Million | -19.71 Million | -15.07 Million | -37.95 Million | -33.46 Million | -27.67 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 82.1 Million | 62.95 Million | -184.74 Million | 27.67 Million | 60.63 Million | -27.14 Million |
| Free Cash Flow | 38.32 Million | 41.5 Million | -84.99 Million | 55.68 Million | 26.88 Million | -2.63 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 18.6 Million | 19.3 Million | -21.37 Million | 30.67 Million | 15.62 Million | 13.61 Million |
| Depreciation & Amortization | - | - | - | 33.64 Million | - | 18.94 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -19.03 Million | - | -109.38 Million |
| Other non-cash items | -18.6 Million | -19.3 Million | 21.37 Million | 8.4 Million | -15.62 Million | -13.61 Million |
| Investing Cash Flow | - | - | - | 60.89 Million | - | 123.27 Thousand |
| Investments in PPE | - | - | - | -15.36 Million | - | -11.29 Million |
| Acquisitions | - | - | - | - | - | 114.22 Thousand |
| Investment purchases | - | - | - | - | - | -22.62 Million |
| Sales/Maturities of investments | - | - | - | 70 Million | - | 33.92 Million |
| Other Investing Activities | - | - | - | 6.26 Million | - | -1.00 |
| Financing Cash Flow | - | - | - | -32.47 Million | - | -966.96 Thousand |
| Debt repayment | - | - | - | -139.89 Million | - | -472.73 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -20.24 Million | - | -494.22 Thousand |
| Accounts receivables | - | - | - | 5.88 Million | - | -35.47 Million |
| Accounts payables | - | - | - | -5.88 Million | - | -44.77 Million |
| Inventory | - | - | - | -10.66 Million | - | -29.14 Million |
| Other working capital | - | - | - | -8.36 Million | - | -2.00 |
| Cash at beginning of period | - | - | - | 290.09 Million | - | 325.7 Million |
| Cash at end of period | - | - | - | 372.2 Million | - | 256.15 Million |
| Capital Expenditure | - | - | - | -15.36 Million | - | -11.29 Million |
| Effect of forex changes on cash | - | - | - | - | - | -9.99 Million |
| Net cash flow / Change in cash | - | - | - | 82.1 Million | - | -69.54 Million |
| Free Cash Flow | - | - | - | 38.32 Million | - | -70 Million |
DQWS
1860
8426
MS-PL
MQBKY
0613